Two-Level ACDF at C4-C5 and C5-C6: Impact on Risks and Benefits
For your two-level ACDF at C4-C5 and C5-C6, the addition of anterior cervical plating (instrumentation) is strongly recommended, as it dramatically reduces pseudarthrosis risk from 4.8% to 0.7% and improves fusion rates from 72% to 91% in two-level constructs. 1
Key Differences: Two-Level vs Single-Level ACDF
Enhanced Fusion Success with Instrumentation
- Anterior cervical plating is specifically recommended for two-level cervical disc degeneration to improve arm pain (Class II evidence, strength of recommendation C). 2
- Plating provides greater stability in multilevel constructs, which is critical for achieving solid arthrodesis across two motion segments. 1
- Without instrumentation, two-level fusions carry substantially higher pseudarthrosis rates (4.8%) compared to instrumented constructs (0.7%). 1
Clinical Outcomes Remain Excellent
- Surgical outcomes for two-level ACDF demonstrate 80-90% success rates for arm pain relief, comparable to single-level procedures. 1
- Motor function recovery occurs in 92.9% of patients, with long-term improvements maintained over 12 months. 1
- Rapid relief of arm/neck pain, weakness, and sensory loss typically occurs within 3-4 months post-operatively. 1
Adjacent Segment Disease Considerations
- Contrary to common assumptions, multilevel arthrodesis carries significantly lower risk of symptomatic adjacent-segment disease compared to single-level fusion (p<0.001). 3
- The annual incidence of new symptomatic disease at adjacent levels is 2.9% per year, with 25.6% of patients developing adjacent-segment disease within 10 years after any anterior cervical arthrodesis. 3
- Single-level arthrodesis involving C5 or C6 with preexisting radiographic degeneration at adjacent levels carries the greatest risk for future adjacent-segment disease. 3
- This evidence supports the recommendation that all degenerated segments causing radiculopathy should be included in the initial fusion, which aligns with your surgeons' recommendation to address both C4-C5 and C5-C6. 3
Surgical Approach and Technical Considerations
Graft Selection
- Allograft is an appropriate and evidence-based choice for two-level fusion, achieving 93.4% fusion rates at 24 months when combined with anterior plating. 1
- Allograft eliminates the 20% rate of prolonged donor site pain associated with iliac crest autograft harvest, without compromising fusion outcomes. 1
- Document your smoking status, as cigarette smoking diminishes fusion rates with allograft, though differences are not always statistically significant. 1
Instrumentation Benefits Beyond Fusion Rates
- Anterior plating maintains cervical lordosis (Class II evidence, strength of recommendation C), which is particularly important in multilevel constructs. 2
- Instrumentation provides immediate structural support and maintains disc height, critical for foraminal decompression at both levels. 1
Realistic Expectations and Outcomes
Pain Relief Timeline
- ACDF provides more rapid reduction of neck and arm pain compared to continued conservative treatment (Class III evidence, strength of recommendation D). 2
- Expect significant symptom improvement within 3-4 months, with 80-90% success rates for arm pain relief. 1, 4
- At 12 months, surgical outcomes demonstrate sustained improvements in motor function, sensation, and pain control. 1
Functional Recovery
- 90.9% functional improvement is reported following surgical intervention for cervical radiculopathy. 1
- Strength improvements are maintained over 12 months but may not achieve 100% return to baseline. 1
- Neck disability index (NDI) scores show significant improvement at 6 months post-operatively compared to conservative treatment. 4
Complication Profile
Overall Safety
- The complication rate for ACDF is approximately 5%, with good or better outcomes in 99% of patients using Odom's criteria. 1
- Two-level constructs with instrumentation do not demonstrate significantly higher complication rates compared to single-level procedures when properly executed. 1
Common Pitfalls to Avoid
- Ensure both C4-C5 and C5-C6 levels meet moderate-to-severe stenosis criteria on imaging, as performing fusion at a level with insufficient pathology is not supported by guidelines. 1
- Verify clinical correlation between your symptoms and the imaging findings at both levels before proceeding. 1
- Avoid premature surgery—confirm you have completed at least 6 weeks of comprehensive conservative therapy including physical therapy, anti-inflammatory medications, and activity modification. 1, 5
Why Two Levels Are Being Recommended
Evidence-Based Rationale
- All degenerated segments causing radiculopathy or myelopathy should be included in an anterior cervical arthrodesis to minimize future adjacent-segment disease risk. 3
- Your imaging likely demonstrates moderate-to-severe foraminal stenosis or disc degeneration at both C4-C5 and C5-C6 that correlates with your clinical presentation. 1
- Addressing both levels simultaneously reduces the risk of requiring revision surgery for adjacent-segment disease, which affects more than one-fourth of patients within 10 years after single-level fusion. 3
Long-Term Perspective
- More than two-thirds of patients who develop symptomatic adjacent-segment disease require additional operative procedures. 3
- By addressing both pathological levels now, you reduce the likelihood of needing a second surgery in the future. 3
Comparison to Conservative Management
When Surgery Is Justified
- You have failed 10 months of conservative treatment including medications, physical therapy, and two epidural steroid injections—this meets the minimum 6-week threshold for surgical consideration. 1, 5
- While 75-90% of cervical radiculopathy patients improve with conservative treatment, you are in the 10-25% who require surgical intervention after failed non-operative management. 1, 5
- Surgery provides more rapid pain relief compared to continued conservative treatment, though at 12 months outcomes may be comparable if conservative treatment were to eventually succeed. 1, 4
Surgical Advantages in Your Case
- ACDF demonstrates superior outcomes in VAS pain scores and NDI scores compared to conservative treatment at all time points up to 12 months. 4
- Rapid relief (within 3-4 months) of arm/neck pain, weakness, and sensory loss is a key advantage over continued conservative management. 1
- Given your 10-month history of failed conservative treatment, further delay is unlikely to provide additional benefit. 1